{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:23:51Z","timestamp":1770931431597,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.autneu.2025.103362","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:58:37Z","timestamp":1763639917000},"page":"103362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders"],"prefix":"10.1016","volume":"262","author":[{"given":"Amro M.","family":"Stino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Gutgsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Eldokla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1099\u20131104","key":"10.1016\/j.autneu.2025.103362_bb0005","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autneu.2025.103362_bb0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11910-023-01307-w","article-title":"Dysautonomia, hypermobility spectrum disorders and mast cell activation syndrome as migraine comorbidities","volume":"23","author":"Blitshteyn","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.autneu.2025.103362_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000503964","article-title":"Survey of mast cell mediator levels from patients presenting with symptoms of mast cell activation","volume":"181","author":"Butterfield","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.autneu.2025.103362_bb0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.clinph.2020.11.024","article-title":"Electrodiagnostic assessment of the autonomic nervous system: a consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology","volume":"132","author":"Cheshire","year":"2021","journal-title":"Clin. Neurophysiol."},{"issue":"728\u2013735","key":"10.1016\/j.autneu.2025.103362_bb0025","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.autneu.2025.103362_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2022.102997","article-title":"Autonomic function testing in long-COVID syndrome patients with orthostatic intolerance","volume":"241","author":"Eldokla","year":"2022","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2025.103362_bb0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/acn3.51557","article-title":"Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: a cross-sectional study","volume":"9","author":"Eldokla","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.autneu.2025.103362_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1742-1241.2003.tb10455.x","article-title":"A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain","volume":"57","author":"Hakim","year":"2003","journal-title":"Int. J. Clin. Pract."},{"issue":"528\u2013529","key":"10.1016\/j.autneu.2025.103362_bb0045","article-title":"Hereditary alpha-tryptasemia in patients with postural orthostatic tachycardia syndrome","volume":"12","author":"Huang","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.autneu.2025.103362_bb0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","article-title":"The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions","volume":"2","author":"Jennings","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.autneu.2025.103362_bb0055","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.autneu.2025.103362_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021002","article-title":"Mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association","volume":"10","author":"Kohno","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.autneu.2025.103362_bb0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-019-08755-8","article-title":"The relationship between hypermobile Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS)","volume":"58","author":"Kucharik","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autneu.2025.103362_bb0070","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0025-6196(12)60631-4","article-title":"Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure","volume":"68","author":"Low","year":"1993","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.autneu.2025.103362_bb0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.autneu.2025.103362_bb0080","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00296-021-04832-4","article-title":"The Beighton Score as a measure of generalised joint hypermobility","volume":"41","author":"Malek","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.autneu.2025.103362_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.anai.2021.07.014","article-title":"Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders","volume":"127","author":"Munoz-Gonzalez","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.autneu.2025.103362_bb0090","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1038\/s41598-024-52368-x","article-title":"Mismatch between subjective and objective dysautonomia","volume":"14","author":"Novak","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.autneu.2025.103362_bb0095","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.jaip.2020.05.005","article-title":"Importance of adequate diagnostic workup for correct diagnosis of advanced systemic mastocytosis","volume":"8","author":"Schwaab","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.autneu.2025.103362_bb0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","article-title":"Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders","volume":"45","author":"Shibao","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.autneu.2025.103362_bb0105","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.autneu.2025.103362_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2010.07.021","article-title":"Beighton score: a valid measure for generalized hypermobility in children","volume":"158","author":"Smits-Engelsman","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.autneu.2025.103362_bb0115","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.anai.2023.10.032","article-title":"Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation","volume":"132","author":"Theoharides","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.autneu.2025.103362_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10286-020-00738-6","volume":"31","author":"Thijs","year":"2021","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.autneu.2025.103362_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.autneu.2025.103362_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.autneu.2025.103362_bb0135","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jaip.2022.05.007","article-title":"Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium","volume":"10","author":"Valent","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.autneu.2025.103362_bb0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070225001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070225001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:53:23Z","timestamp":1770929603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070225001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S1566070225001249"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2025.103362","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2025.103362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103362"}}